Fatal Renal Failure Caused by Diethylene Glycol in Paracetamol Elixir: the Bangladesh Epidemic
Overview
Affiliations
Objective: To determine the cause of a large increase in the number of children with unexplained renal failure.
Design: Case-control study.
Setting: Children's hospital in Dhaka, Bangladesh.
Subjects: Cases were all 339 children with initially unexplained renal failure; controls were 90 children with cause of renal failure identified; all were admitted to hospital during 35 months after January 1990.
Main Outcome Measures: Differences between the case and control patients in clinical and histological features and outcome; toxicological examination of 69 bottles of paracetamol from patients and pharmacies.
Results: Compared with children with an identified cause for their renal failure, children with initially unexplained renal failure were significantly (P < 0.05) more likely to have hepatomegaly (58% v 33%), oedema (37% v 20%), and hypertension (58% v 23%); to have a higher serum creatinine concentration (mean 519 mumol/l v 347 mumol/l) and lower serum bicarbonate concentration (10.1 mmol/l v 12.4 mmol/l); to have been given a drug for fever (91% v 31%); to have ingested a brand of paracetamol shown to contain diethylene glycol (20% v 0%); and to have died in hospital (70% v 33%). Diethylene glycol was identified in 19 bottles of paracetamol, from 7 of 28 brands tested. In the 12 months after a government ban on the sale of paracetamol elixir, new cases of renal failure decreased by 54%, and cases of unexplained renal failure decreased by 84%.
Conclusion: Paracetamol elixirs with diethylene glycol as a diluent were responsible for a large outbreak of fatal renal failure in Bangladesh.
Malvar G, Gunasekaran D, Vaghari Mehr N, Ishibe S, Moeckel G Kidney Med. 2024; 6(2):100758.
PMID: 38304581 PMC: 10831151. DOI: 10.1016/j.xkme.2023.100758.
Soleman S, Adnan M, Sudiarto H, Mahathma S, Tazkia A, Firdaus H Clin Exp Pediatr. 2024; 67(8):395-402.
PMID: 38186259 PMC: 11298774. DOI: 10.3345/cep.2023.01039.
Quality of medicines in Sri Lanka: a retrospective review of safety alerts.
Tharmalinga Sharma J, Ketharam M, Herath K, Shobia S BMC Health Serv Res. 2023; 23(1):980.
PMID: 37700302 PMC: 10496228. DOI: 10.1186/s12913-023-09995-3.
Murtalibova N, Sethi S, Tojiboev J, Soni K, Raina R Kidney Int Rep. 2023; 8(8):1696-1697.
PMID: 37547527 PMC: 10403662. DOI: 10.1016/j.ekir.2023.06.006.
Rahman M, Yoshida N, Tsuboi H, Karmoker J, Kabir N, Schaefermann S Sci Rep. 2022; 12(1):234.
PMID: 34997152 PMC: 8741935. DOI: 10.1038/s41598-021-04309-1.